Small South Africa patient study shows Omicron breaking through COVID-19 vaccine booster shots

[edwarde2]

https://www.channelnewsasia.com/wor...hrough-covid-19-vaccine-booster-shots-2384951

 

[platee]

Good stuff

 

[SimpliCity2k]

same old story... simi breaking thru?

 

[Aaron_soh80]

https://www.channelnewsasia.com/wor...hrough-covid-19-vaccine-booster-shots-2384951

No no..Mr ong say booster can protect against this omircon..

 

[swageat]

https://www.channelnewsasia.com/wor...hrough-covid-19-vaccine-booster-shots-2384951

A small study of seven COVID-19 cases in South Africa shows the Omicron variant can break through booster vaccine shots, one of the scientists involved said on Thursday (Dec 16).

A group of seven German visitors to Cape Town, aged between 25 and 39, were infected at some point in late November or early December with confirmed cases of the Omicron coronavirus variant. A copy of the study seen by Reuters said they all suffered only mild to moderate symptoms and none required hospitalisation.



Of the group, six were fully vaccinated with the Pfizer-BioNTech vaccine, of whom five had also had a booster Pfizer shot while the sixth had received a booster dose of the Moderna vaccine.

A seventh had received an initial dose of AstraZeneca's vaccine, followed by a second and then third booster dose of Pfizer. None had reported past infection with COVID-19.

The infections occurred between one and two months after receipt of the booster shot.



Wolfgang Preiser, a virologist at Stellenbosch University and one of the study's co-authors, told Reuters the study was currently under peer review. He said the study showed infection was possible and caused symptomatic disease even after boosted immunisation.

A much bigger real world study of 581 people in Britain showed booster vaccines significantly restore protection against mild disease caused by the Omicron variant, in part reversing an otherwise steep drop in vaccine effectiveness, the UK Health Security Agency said last week.

 

[clon33]

US CDC confirm that 80% omicron cases are fully vaccinated. 33% had booster somemore.

2% hospitalization.
0% death.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7050e1.htm

Details are available for 43 cases of COVID-19 attributed to the Omicron variant; 25 (58%) were in persons aged 18–39 years (Table). The earliest date of symptom onset was November 15 in a person with a history of international travel. Fourteen (33%) persons reported international travel during the 14 days preceding symptom onset or receipt of a positive test result. Among these cases of COVID-19 attributed to the Omicron variant, 34 (79%) occurred in persons who completed the primary series of an FDA-authorized or approved COVID-19 vaccine ≥14 days before symptom onset or receipt of a positive SARS-CoV-2 test result, including 14 who had received an additional or booster dose; five of the 14 persons had received the additional dose <14 days before symptom onset. Six (14%) persons had a documented previous SARS-CoV-2 infection. The most commonly reported symptoms were cough, fatigue, and congestion or runny nose. One vaccinated patient was hospitalized for 2 days, and no deaths have been reported to date. Case investigations have identified exposures associated with international and domestic travel, large public events, and household transmission.

 

[needsomeadvice]

US CDC confirm that 80% omicron cases are fully vaccinated. 33% had booster somemore.

2% hospitalization.
0% death.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7050e1.htm

Details are available for 43 cases of COVID-19 attributed to the Omicron variant; 25 (58%) were in persons aged 18–39 years (Table). The earliest date of symptom onset was November 15 in a person with a history of international travel. Fourteen (33%) persons reported international travel during the 14 days preceding symptom onset or receipt of a positive test result. Among these cases of COVID-19 attributed to the Omicron variant, 34 (79%) occurred in persons who completed the primary series of an FDA-authorized or approved COVID-19 vaccine ≥14 days before symptom onset or receipt of a positive SARS-CoV-2 test result, including 14 who had received an additional or booster dose; five of the 14 persons had received the additional dose <14 days before symptom onset. Six (14%) persons had a documented previous SARS-CoV-2 infection. The most commonly reported symptoms were cough, fatigue, and congestion or runny nose. One vaccinated patient was hospitalized for 2 days, and no deaths have been reported to date. Case investigations have identified exposures associated with international and domestic travel, large public events, and household transmission.

0 deaths is very good news for vaccinated persons..

 

[poooooo]

OngYicron will just ask you jab more will prevent death from Omnicron. No need scientific evidence huan.

 

[PetKat]

US CDC confirm that 80% omicron cases are fully vaccinated. 33% had booster somemore.

2% hospitalization.
0% death.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7050e1.htm

Details are available for 43 cases of COVID-19 attributed to the Omicron variant; 25 (58%) were in persons aged 18–39 years (Table). The earliest date of symptom onset was November 15 in a person with a history of international travel. Fourteen (33%) persons reported international travel during the 14 days preceding symptom onset or receipt of a positive test result. Among these cases of COVID-19 attributed to the Omicron variant, 34 (79%) occurred in persons who completed the primary series of an FDA-authorized or approved COVID-19 vaccine ≥14 days before symptom onset or receipt of a positive SARS-CoV-2 test result, including 14 who had received an additional or booster dose; five of the 14 persons had received the additional dose <14 days before symptom onset. Six (14%) persons had a documented previous SARS-CoV-2 infection. The most commonly reported symptoms were cough, fatigue, and congestion or runny nose. One vaccinated patient was hospitalized for 2 days, and no deaths have been reported to date. Case investigations have identified exposures associated with international and domestic travel, large public events, and household transmission.

Seems like very mild ... Covid ownself fix ownself liao